Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Vitreoretinopathy”

50 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 50 results

Large-scale testing (Phase 3)Active Not RecruitingNCT05660447
What this trial is testing

A Multi-Center Study on the Use of Rho-Kinase Inhibitor to Reduce or Prevent PVR in RRD Eyes at High Risk for PVR

Who this might be right for
Rhegmatogenous Retinal DetachmentProliferative Vitreoretinopathy
Wills Eye 80
Testing effectiveness (Phase 2)Study completedNCT02192970
What this trial is testing

Bevacizumab Against Recurrent Retinal Detachment

Who this might be right for
Retinal DetachmentProliferative Vitreoretinopathy
University of Wisconsin, Madison 101
Not applicableNot Yet RecruitingNCT05538156
What this trial is testing

Internal Limiting Membrane Peeling in Retinal Detachment Surgery

Who this might be right for
Retinal DetachmentProliferative Vitreoretinopathy
Central Hospital, Nancy, France 126
Early research (Phase 1)WithdrawnNCT04830878
What this trial is testing

Methotrexate For The Prevention and Treatment of Proliferative Vitreoretinopathy in Pediatric Patients

Who this might be right for
Proliferative Vitreoretinopathy
Stanford University
Not applicableNot Yet RecruitingNCT07386678
What this trial is testing

Study of Imaging and Molecular Biomarkers in Uncomplicated Rhegmatogenous Retinal Detachment

Who this might be right for
Retinal Detachment RhegmatogenousProliferative VitreoretinopathyProliferative Vitreoretinopathy in Rhegmatogenous Retinal Detachment
University College, London 50
Early research (Phase 1)Not Yet RecruitingNCT06425419
What this trial is testing

The Safety and Efficacy of Intravitreal Topotecan for the Treatment of Proliferative Vitreoretinopathy

Who this might be right for
Proliferative VitreoretinopathyProliferative Vitreo-RetinopathyRhegmatogenous Retinal Detachment
Massachusetts Eye and Ear Infirmary 50
Testing effectiveness (Phase 2)UnknownNCT04580147
What this trial is testing

Intravitreal Aflibercept for the Prevention of Proliferative Vitreoretinopathy Following Retinal Detachment Repair

Who this might be right for
Retinal Detachment With Multiple Breaks, Unspecified EyeProliferative Vitreoretinopathy
M. Ali Khan, MD 150
Not applicableStudy completedNCT01108068
What this trial is testing

Trial of Lithium Carbonate for Treatment of Osteoporosis-pseudoglioma Syndrome

Who this might be right for
Osteoporosis Pseudoglioma
University of Maryland, Baltimore 26
Large-scale testing (Phase 3)UnknownNCT04482543
What this trial is testing

Repeated Methotrexate for Proliferative Vitreoretinopathy Grade C

Who this might be right for
Proliferative Vitreoretinopathy
Shahid Beheshti University of Medical Sciences 74
Not applicableStudy completedNCT04490876
What this trial is testing

Outcomes of Extensive Brilliant Blue G-Assisted Internal Limiting Membrane Peeling in Proliferative Vitreoretinopathy

Who this might be right for
Proliferative Vitreoretinopathy
Centro Oftalmológico Dr Charles 14
Not applicableStudy completedNCT01255293
What this trial is testing

Comparative Study of 1000 Centistoke Versus 5000 Centistoke Silicone Oil for Repair of Complex Retinal Detachments

Who this might be right for
Retinal DetachmentVitrectomyProliferative Vitreoretinopathy+1 more
Mid Atlantic Retina 15
Testing effectiveness (Phase 2)Looking for participantsNCT06033703
What this trial is testing

Topical Netarsudil for the Prevention of Proliferative Vitreoretinopathy in Patients With Retinal Detachment

Who this might be right for
Rhegmatogenous Retinal DetachmentProliferative Vitreoretinopathy
Massachusetts Eye and Ear Infirmary 48
Large-scale testing (Phase 3)WithdrawnNCT00403702
What this trial is testing

Comparison High-density Silicone Oils in Retinal Detachment

Who this might be right for
Retinal Detachment
Asociación para Evitar la Ceguera en México
Very early researchStudy completedNCT03727776
What this trial is testing

Adrenocorticotropic Hormone (ACTH) for Post-op Inflammation in Proliferative Vitreoretinopathy (PVR)

Who this might be right for
Proliferative Vitreoretinopathy
Johns Hopkins University 11
Testing effectiveness (Phase 2)Looking for participantsNCT05523869
What this trial is testing

Intravitreal Topotecan in the Repair of Rhegmatogenous Retinal Detachment with Proliferative Vitreoretinopathy

Who this might be right for
Proliferative Vitreoretinopathy in Rhegmatogenous Retinal Detachment
Unity Health Toronto 50
Not applicableUnknownNCT05561569
What this trial is testing

Air Versus Gas Tamponade in Primary Retinal Detachment

Who this might be right for
Retinal DetachmentProliferative Vitreoretinopathy
Benha University 40
Large-scale testing (Phase 3)Study completedNCT04136366
What this trial is testing

The GUARD Trial - Part 1: A Phase 3 Clinical Trial for Prevention of Proliferative Vitreoretinopathy

Who this might be right for
Proliferative Vitreoretinopathy
Aldeyra Therapeutics, Inc. 106
Not applicableUnknownNCT05415826
What this trial is testing

Ozurdex in Reducing PVR After Vitreotomy in PDR

Who this might be right for
Diabetic Retinopathy
Peking University People's Hospital 30
Large-scale testing (Phase 3)UnknownNCT00370279
What this trial is testing

Surgical Management of Pseudophakic and Aphakic Retinal Detachment; a Randomized Clinical Trial

Who this might be right for
Pseudophakic Retinal DetachmentAphakic Retinal Detachment
Shahid Beheshti University of Medical Sciences
Not applicableStudy completedNCT01860586
What this trial is testing

Eye Injections of Bevacizumab for Lowering Risk of Scar Tissue in the Retina and Repeated Retinal Detachment.

Who this might be right for
Retinal DetachmentVitreoretinopathy Proliferative
Wills Eye 20
Load More Results